A phase I/2 randomized double-blind placebo-controlled, single-dose dose escallation study of KB001 in CF patients infected with p. aeruginosa
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A